Literature DB >> 2783433

Behavioral disturbance, cognitive dysfunction, and functional skill. Prevalence and relationship in Alzheimer's disease.

L Teri1, S Borson, H A Kiyak, M Yamagishi.   

Abstract

The nature and severity of behavioral problems, and their relationship to cognitive and functional abilities, was investigated in 56 community-residing patients with Alzheimer's disease. Measures evaluated three domains of function: behavior, cognition and activities of daily living. Problems of cognitive functioning, such as memory loss, confusion, and disorientation were most prevalent, reported to occur in 84%, 82%, and 64% of the sample, respectively. Problems with activity and emotional distress were next, affecting 20 to 43% of the sample. The mean number of problems reported was 10 per patient. Twenty-two percent of caregivers reported a minimum of 15 problems occurring at least twice a week and no caregiver reported an absence of problems. Male patients were reported to have more behavioral difficulties. Level of behavioral disturbance was largely unrelated to cognitive or functional ability. Age was unrelated to cognitive or behavioral disturbance but significantly related to activities of daily living. Results indicated that behavioral problems are prevalent and pervasive in even moderately impaired community-residing Alzheimer disease patients, and that age may be more important than level of cognitive dysfunction in predicting difficulties with activities of daily living.

Entities:  

Mesh:

Year:  1989        PMID: 2783433     DOI: 10.1111/j.1532-5415.1989.tb05868.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  15 in total

Review 1.  Behavioural problems associated with dementia: the role of newer antipsychotics.

Authors:  G Stoppe; C A Brandt; J H Staedt
Journal:  Drugs Aging       Date:  1999-01       Impact factor: 3.923

Review 2.  Clinical and economic factors in the treatment of behavioural and psychological symptoms of dementia.

Authors:  M E Hemels; K L Lanctôt; M Iskedjian; T R Einarson
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

3.  Investigating emergent symptomatology as an outcome measure in a behavioral study of Alzheimer's disease.

Authors:  Rochelle E Tractenberg; Anthony Gamst; Ronald G Thomas; Marian Patterson; Lon S Schneider; Leon J Thal
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2002       Impact factor: 2.198

4.  Object perception impairments predict instrumental activities of daily living dependence in Alzheimer's disease.

Authors:  Angela L Jefferson; Lamia P Barakat; Tania Giovannetti; Robert H Paul; Guila Glosser
Journal:  J Clin Exp Neuropsychol       Date:  2006-08       Impact factor: 2.475

Review 5.  A review of quality of life in Alzheimer's disease. Part 2: Issues in assessing drug effects.

Authors:  S S Salek; M D Walker; A J Bayer
Journal:  Pharmacoeconomics       Date:  1998-12       Impact factor: 4.981

6.  Affective behavioural disturbances in Alzheimer's disease and ischaemic vascular disease.

Authors:  R Hargrave; L C Geck; B Reed; D Mungas
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-01       Impact factor: 10.154

7.  Gabapentin for the treatment of behavioural alterations in dementia: preliminary 15-month investigation.

Authors:  Rita Moretti; Paola Torre; Rodolfo M Antonello; Giuseppe Cazzato; Antonio Bava
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

Review 8.  Sex differences in Alzheimer's disease: Understanding the molecular impact.

Authors:  Carlos A Toro; Larry Zhang; Jiqing Cao; Dongming Cai
Journal:  Brain Res       Date:  2019-05-23       Impact factor: 3.252

9.  Behavioral disturbances in dementia.

Authors:  Franz Müller-Spahn
Journal:  Dialogues Clin Neurosci       Date:  2003-03       Impact factor: 5.986

Review 10.  Heat therapy: possible benefits for cognitive function and the aging brain.

Authors:  Alex T Von Schulze; Fengyan Deng; Jill K Morris; Paige C Geiger
Journal:  J Appl Physiol (1985)       Date:  2020-09-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.